Loading publications…
The last 5 uploaded publications
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma and vascular invasion or extrahepatic spread: A subanalysis from the SHARP trial
Morris Sherman, Vincenzo Mazzaferro, D. Amadori, Julia Seitz, M. Moscovici, Ming Shan, Andrea Nadel, D. Voliotis, Josep M. Llovet, Jordi Bruix (2008). Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma and vascular invasion or extrahepatic spread: A subanalysis from the SHARP trial. Journal of Clinical Oncology, 26(15_suppl), pp. 4584-4584, DOI: 10.1200/jco.2008.26.15_suppl.4584.
Article145 days ago67 EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): SUBANALYSIS OF SHARP TRIAL BASED ON BARCELONA CLINIC LIVER CANCER (BCLC) STAGE
Jordi Bruix, Jean‐Luc Raoul, Morris Sherman, Ming Shan, Giuseppe Lentini, Andrea Nadel, D. Voliotis, Josep M. Llovet (2009). 67 EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): SUBANALYSIS OF SHARP TRIAL BASED ON BARCELONA CLINIC LIVER CANCER (BCLC) STAGE. Journal of Hepatology, 50, pp. S28-S29, DOI: 10.1016/s0168-8278(09)60069-6.
Article145 days agoClinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Jordi Bruix, Morris Sherman, Josep M. Llovet, Michel Beaugrand, Riccardo Lencioni, Andrew K. Burroughs, Erik Christensen, Luigi Pagliaro, Massimo Colombo, Juan Rodés (2001). Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference. Journal of Hepatology, 35(3), pp. 421-430, DOI: 10.1016/s0168-8278(01)00130-1.
Article145 days agoHepatocellular carcinoma
Josep M. Llovet, Jessica Zucman‐Rossi, Eli Pikarsky, Bruno Sangro, M. Schwartz, Morris Sherman, Gregory J. Gores (2016). Hepatocellular carcinoma. Nature Reviews Disease Primers, 2(1), DOI: 10.1038/nrdp.2016.18.
Article145 days agoDesign and Endpoints of Clinical Trials in Hepatocellular Carcinoma
Josep M. Llovet, Adrian M. Di Bisceglie, Jordi Bruix, Barnett S. Kramer, Riccardo Lencioni, Andrew X. Zhu, Morris Sherman, Myron Schwartz, Michael T. Lotze, Jayant A. Talwalkar, Gregory J. Gores (2008). Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma. JNCI Journal of the National Cancer Institute, 100(10), pp. 698-711, DOI: 10.1093/jnci/djn134.
Article145 days ago